Banach, M, Katsiki, N, Latkovskis, G, Rizzo, M, Pella, D, Penson, PE, Reiner, Z and Cicero, A (2021) Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia. Archives of Medical Science. ISSN 1734-1922

Preview

Text Postmarketing.pdf - Published Version Available under License Creative Commons Attribution Non-commercial Share Alike. Download (80kB) | Preview

Abstract

Introduction: In the absence of a European standardized postmarketing food supplement surveillance system (nutrivigilance), some member states and companies have developed their own approaches to monitoring potential adverse reactions to secure a high level of product safety. This paper describes the use of a nutrivigilance system in monitoring the incidence of spontaneously reported suspected adverse reactions associated with food supplements containing red yeast rice (RYR). Material and methods: We report the data from a widely used product marketed under the trademark Armolipid/Armolipid Plus. Postmarketing information was collected in a voluntary nutrivigilance system established by the manufacturing company (Meda Pharma SpA, a Viatris Company, Monza, Italy). From 1st October 2004 to 31st December 2019, this system captured cases of suspected adverse reactions spontaneously reported by consumers, healthcare professionals, health authorities, regardless of causality. Results: The total number of case reports received mentioning the RYR food supplement product line was 542, in which 855 adverse events (AEs) were reported. The total reporting rate of AEs was estimated to be 0.037% of 2,287,449 exposed consumers. Of the 542 cases, 21 (0.0009% of exposed consumers) included suspected serious adverse events (SAEs). After careful investigation, 6 cases (0.0003% of consumers exposed) and 6 AEs were assessed by the manufacturer as serious and potentially related to exposure to the above-mentioned RYR-based nutraceutical. Conclusions: This nutrivigilance-derived data analysis clearly demonstrates a low prevalence of suspected adverse events associated with the red yeast rice product line. Consumer safety of food supplements could be generally improved by raising awareness of the importance of following the indications and warnings detailed in a food supplement’s labeling.

Item Type:	Article
Additional Information:	Banach, M., Katsiki, N., Latkovskis, G., Rizzo, M., Pella, D., Penson, P. E., Reiner, Ž., and Cicero, A. F. (2021). Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia. Archives of Medical Science.
Uncontrolled Keywords:	1103 Clinical Sciences
Subjects:	T Technology > TX Home economics > TX341 Nutrition. Foods and food supply R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RS Pharmacy and materia medica
Divisions:	Pharmacy & Biomolecular Sciences
Publisher:	Termedia Publishing House
Date Deposited:	05 Mar 2021 12:26
Last Modified:	04 Sep 2021 05:49
DOI or ID number:	10.5114/aoms/133716
URI:	https://researchonline.ljmu.ac.uk/id/eprint/14561

View Item